Compare

Epithalon vs IGF-1 LR3

Side-by-side observational reports from PeptIQ users. This compares self-reported patterns — not clinical head-to-head trials.

Last reviewed . By the PeptIQ team.

Observational reporting only — not medical advice. Does not recommend doses, protocols, or treatments.

Epithalon

76 community reports

Overall experience

From check-in ratings — separate from side effects logged below. Side effects are logged separately from overall experience. A favorable check-in can still include nausea, fatigue, or injection-site reactions.

Favorable 70% · Mixed 18% · Unfavorable overall 12%

Most reported benefits

Benefits users selected when logging a favorable or mixed check-in.

Sleep quality
-33
Lean mass
-84
Joint comfort
-23
Recovery
-83
Digestive comfort
0

Most logged side effects

Side effects are logged separately from overall experience. A favorable check-in can still include nausea, fatigue, or injection-site reactions.

Water retention
-117
Appetite loss
-5
Injection site reaction
-58
Anxiety
-87
Flushing
-1

Self-reported dose per injection

Median bucket: 100–200 mcg · Most common: 100–200 mcg

Reports span 0–1000 mcg

0–10
3
10–25
6
25–50
11
50–100
17
100–200
24
200–400
21
400–600
12
600–1000
4

Anonymized self-reports from PeptIQ users — not prescribing guidance. Buckets group similar logged amounts; open-ended top buckets mean “at least” that dose.

Common discussion topics

timing40stacking38side effects36epithalon9

How repeat users are trending

Among repeat reporters, 65% said they felt similar to their last entry, 38% more positive, and 20% more negative.

Overall, repeat reporters leaned more positive than their previous entry.

Median gap between entries: 21 days · Based on 17 repeat reporters

IGF-1 LR3

764 community reports

Overall experience

From check-in ratings — separate from side effects logged below. Side effects are logged separately from overall experience. A favorable check-in can still include nausea, fatigue, or injection-site reactions.

Favorable 68% · Mixed 16% · Unfavorable overall 16%

Most reported benefits

Benefits users selected when logging a favorable or mixed check-in.

Mood
-117
Focus
-162
Sleep quality
-145
Lean mass
-166
Joint comfort
-101

Most logged side effects

Side effects are logged separately from overall experience. A favorable check-in can still include nausea, fatigue, or injection-site reactions.

Fatigue
-21
Nausea
-83
Water retention
0
Appetite loss
10
Injection site reaction
-101

Self-reported dose per injection

Median bucket: 100–200 mcg · Most common: 100–200 mcg

Reports span 25–600 mcg

25–50
2
50–100
13
100–200
22
200–400
11
400–600
2

Anonymized self-reports from PeptIQ users — not prescribing guidance. Buckets group similar logged amounts; open-ended top buckets mean “at least” that dose.

Common discussion topics

timing48stacking31side effects34igf-1 lr322

How repeat users are trending

Among repeat reporters, 63% said they felt similar to their last entry, 42% more positive, and 18% more negative.

Overall, repeat reporters leaned more positive than their previous entry.

Median gap between entries: 28 days · Based on 168 repeat reporters

Sources (17)

Published sources linked on the Epithalon and IGF-1 LR3 wiki pages.

  1. PubMed

    Effect of Epitalon on biomarkers of aging, life span and spontaneous tumor incidence

    Anisimov VN, Khavinson VK, Popovich IG, et al. Biogerontology. 2003

    Source
    Wiki study page →
  2. PubMed

    Epitalon peptide induces telomerase activity in human somatic cells

    Khavinson VK, Bondarev IE, Butyugov AA. Bull Exp Biol Med. 2003

    Source
    Wiki study page →
  3. ClinicalTrials.gov

    Epitalon / epithalon studies on ClinicalTrials.gov

    ClinicalTrials.gov. Clinical trial registry. 2024

    Source
    Wiki study page →
  4. PubMed

    Peptide promotes overcoming of the division limit in human somatic cell

    Khavinson VKh, Bondarev IE, Butyugov AA, et al. Bulletin of experimental biology and medicine. 2004

    Source
    Wiki study page →
  5. PubMed

    Reparative effect of epithalon on pineal gland ultrastructure in gamma-irradiated rats

    Khavinson VK, Yakovleva ND, Popuchiev VV, et al. Bull Exp Biol Med. 2001

    Source
    Wiki study page →
  6. PubMed

    Effect of pineal peptides on neuroendocrine system after pinealectomy

    Khavinson VKh, Kvetnoi IM, Popuchiev VV, et al. Arkh Patol. 2001

    Source
    Wiki study page →
  7. PubMed

    Modulating effects of epithalamin and epithalon on the functional morphology of the spleen in old pinealectomized rats

    Khavinson VK, Konovalov SS, Yuzhakov VV, et al. Bull Exp Biol Med. 2001

    Source
    Wiki study page →
  8. PubMed

    Pineal-regulating tetrapeptide epitalon improves eye retina condition in retinitis pigmentosa

    Khavinson V, Razumovsky M, Trofimova S, et al. Neuro Endocrinol Lett. 2002

    Source
    Wiki study page →
  9. PubMed

    AEDG Peptide (Epitalon) Stimulates Gene Expression and Protein Synthesis during Neurogenesis: Possible Epigenetic Mechanism

    Khavinson V, Diomede F, Mironova E, et al. Molecules. 2020

    Source
    Wiki study page →
  10. Review Article

    Therapeutic Peptides in Orthopaedics: Applications, Challenges, and Future Directions

    Rahman OF, Lee SJ, Seeds WA. J Am Acad Orthop Surg Glob Res Rev. 2026

    Source
    Wiki study page →
  11. PubMed

    Insulin-like growth factor-I and its binding proteins in sport and exercise medicine

    Baxter RC. Endocr Rev. 2011

    Source
    Wiki study page →
  12. ClinicalTrials.gov

    IGF-1 LR3 studies on ClinicalTrials.gov

    ClinicalTrials.gov. Clinical trial registry. 2024

    Source
    Wiki study page →
  13. PubMed

    Intranasal long R3 insulin-like growth factor-1 treatment promotes amyloid plaque remodeling in cerebral cortex but fails to preserve cognitive function in male 5XFAD mice

    Engel MG, Narayan S, Cui MH, et al. Journal of Alzheimer's disease : JAD. 2025

    Source
    Wiki study page →
  14. PubMed

    Revolutionary decellularized Alstroemeria stem-based nerve conduit integrated with GelMA and controlled IGF-1 LR3 release for enhanced rat sciatic nerve regeneration

    Yavuz E, Sağır MS, Ercan A, et al. International journal of biological macromolecules. 2025

    Source
    Wiki study page →